Ann Hynes
Stock Analyst at Mizuho
(4.39)
# 362
Out of 4,989 analysts
253
Total ratings
64.36%
Success rate
12.41%
Average return
Main Sectors:
Stocks Rated by Ann Hynes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Maintains: Neutral | $32 → $22 | $23.02 | -4.43% | 12 | Aug 14, 2025 | |
| UNH UnitedHealth Group | Maintains: Outperform | $350 → $300 | $341.30 | -12.10% | 20 | Aug 7, 2025 | |
| MEDP Medpace Holdings | Maintains: Outperform | $328 → $510 | $498.09 | +2.39% | 3 | Jul 25, 2025 | |
| IQV IQVIA Holdings | Maintains: Outperform | $190 → $225 | $187.83 | +19.79% | 13 | Jul 25, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Outperform | $173 → $225 | $170.80 | +31.73% | 16 | Jul 25, 2025 | |
| THC Tenet Healthcare | Maintains: Outperform | $184 → $194 | $194.06 | -0.03% | 15 | Jul 11, 2025 | |
| MOH Molina Healthcare | Maintains: Outperform | $400 → $330 | $181.87 | +81.45% | 9 | Jul 11, 2025 | |
| FTRE Fortrea Holdings | Maintains: Neutral | $8 → $7 | $9.64 | -27.39% | 4 | Jul 11, 2025 | |
| CNC Centene | Maintains: Neutral | $71 → $40 | $32.70 | +22.32% | 8 | Jul 11, 2025 | |
| DGX Quest Diagnostics | Maintains: Outperform | $178 → $189 | $184.69 | +2.33% | 15 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $305 → $316 | $257.87 | +22.54% | 8 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $455 → $505 | $317.89 | +58.86% | 4 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $175 → $155 | $153.89 | +0.72% | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $76 | $75.13 | +1.16% | 10 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $19 → $18 | $13.03 | +38.14% | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $16.56 | -9.42% | 11 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $110 → $120 | $147.47 | -18.63% | 8 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $20 | $27.60 | -27.54% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $28 | $20.87 | +34.16% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $93 → $95 | $126.12 | -24.67% | 8 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $370 → $385 | $288.62 | +33.39% | 10 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $200 | $194.16 | +3.01% | 15 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $242 → $268 | $2.68 | +9,900.00% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $450 → $505 | $697.00 | -27.55% | 19 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $257 → $230 | $278.90 | -17.53% | 15 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $275 | $407.24 | -32.47% | 20 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $50 | $21.87 | +128.62% | 2 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $57 | $1.47 | +3,777.55% | 1 | Sep 21, 2017 |
Acadia Healthcare Company
Aug 14, 2025
Maintains: Neutral
Price Target: $32 → $22
Current: $23.02
Upside: -4.43%
UnitedHealth Group
Aug 7, 2025
Maintains: Outperform
Price Target: $350 → $300
Current: $341.30
Upside: -12.10%
Medpace Holdings
Jul 25, 2025
Maintains: Outperform
Price Target: $328 → $510
Current: $498.09
Upside: +2.39%
IQVIA Holdings
Jul 25, 2025
Maintains: Outperform
Price Target: $190 → $225
Current: $187.83
Upside: +19.79%
ICON Public Limited Company
Jul 25, 2025
Maintains: Outperform
Price Target: $173 → $225
Current: $170.80
Upside: +31.73%
Tenet Healthcare
Jul 11, 2025
Maintains: Outperform
Price Target: $184 → $194
Current: $194.06
Upside: -0.03%
Molina Healthcare
Jul 11, 2025
Maintains: Outperform
Price Target: $400 → $330
Current: $181.87
Upside: +81.45%
Fortrea Holdings
Jul 11, 2025
Maintains: Neutral
Price Target: $8 → $7
Current: $9.64
Upside: -27.39%
Centene
Jul 11, 2025
Maintains: Neutral
Price Target: $71 → $40
Current: $32.70
Upside: +22.32%
Quest Diagnostics
Apr 9, 2025
Maintains: Outperform
Price Target: $178 → $189
Current: $184.69
Upside: +2.33%
Apr 9, 2025
Maintains: Outperform
Price Target: $305 → $316
Current: $257.87
Upside: +22.54%
Apr 9, 2025
Maintains: Outperform
Price Target: $455 → $505
Current: $317.89
Upside: +58.86%
Apr 9, 2025
Maintains: Neutral
Price Target: $175 → $155
Current: $153.89
Upside: +0.72%
Apr 9, 2025
Maintains: Outperform
Price Target: $70 → $76
Current: $75.13
Upside: +1.16%
Apr 9, 2025
Maintains: Outperform
Price Target: $19 → $18
Current: $13.03
Upside: +38.14%
Nov 19, 2024
Maintains: Neutral
Price Target: $13 → $15
Current: $16.56
Upside: -9.42%
Nov 4, 2024
Maintains: Neutral
Price Target: $110 → $120
Current: $147.47
Upside: -18.63%
Nov 4, 2024
Maintains: Outperform
Price Target: $17 → $20
Current: $27.60
Upside: -27.54%
Aug 19, 2024
Initiates: Outperform
Price Target: $28
Current: $20.87
Upside: +34.16%
Apr 25, 2024
Maintains: Buy
Price Target: $93 → $95
Current: $126.12
Upside: -24.67%
Mar 8, 2024
Maintains: Buy
Price Target: $370 → $385
Current: $288.62
Upside: +33.39%
Mar 6, 2024
Maintains: Buy
Price Target: $175 → $200
Current: $194.16
Upside: +3.01%
Feb 23, 2024
Maintains: Buy
Price Target: $242 → $268
Current: $2.68
Upside: +9,900.00%
Feb 9, 2024
Maintains: Neutral
Price Target: $450 → $505
Current: $697.00
Upside: -27.55%
Oct 31, 2023
Maintains: Buy
Price Target: $257 → $230
Current: $278.90
Upside: -17.53%
Oct 25, 2023
Maintains: Buy
Price Target: $325 → $275
Current: $407.24
Upside: -32.47%
Jul 11, 2023
Maintains: Buy
Price Target: $48 → $50
Current: $21.87
Upside: +128.62%
Sep 21, 2017
Initiates: Neutral
Price Target: $57
Current: $1.47
Upside: +3,777.55%